Kosta Kostov

560 total citations
11 papers, 182 citations indexed

About

Kosta Kostov is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kosta Kostov has authored 11 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Kosta Kostov's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Kosta Kostov is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Kosta Kostov collaborates with scholars based in Bulgaria, Russia and Slovakia. Kosta Kostov's co-authors include Thomas M. File, Ognian Georgiev, Lionel A. Mandell, Glenn S. Tillotson, Ružena Tkáčová, Adam Barczyk, Arschang Valipour, Branislava Milenković, Vladimír Koblížek and Marc Miravitlles and has published in prestigious journals such as European Respiratory Journal, Journal of Antimicrobial Chemotherapy and Respiratory Medicine.

In The Last Decade

Kosta Kostov

11 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosta Kostov Bulgaria 6 106 64 59 21 19 11 182
Alev Gürgün Türkiye 10 188 1.8× 66 1.0× 58 1.0× 39 1.9× 15 0.8× 33 279
Michael G. Sherenian United States 8 52 0.5× 56 0.9× 18 0.3× 4 0.2× 17 0.9× 19 217
Lindsay McCauley United States 5 159 1.5× 143 2.2× 70 1.2× 56 2.7× 12 0.6× 7 345
Sonal Jindal India 5 44 0.4× 17 0.3× 52 0.9× 76 3.6× 10 0.5× 14 160
Tammy Abuan United States 9 325 3.1× 63 1.0× 150 2.5× 79 3.8× 25 1.3× 9 460
François Fournel France 6 30 0.3× 9 0.1× 64 1.1× 35 1.7× 19 1.0× 9 130
Andrea Gramegna Italy 7 123 1.2× 15 0.2× 47 0.8× 7 0.3× 8 0.4× 11 198
Michalis Agrafiotis Greece 9 139 1.3× 15 0.2× 96 1.6× 108 5.1× 11 0.6× 17 262
Esther Antón Spain 6 189 1.8× 134 2.1× 45 0.8× 16 0.8× 9 0.5× 11 303
Marco V. Ranieri Italy 7 162 1.5× 21 0.3× 22 0.4× 57 2.7× 5 0.3× 8 217

Countries citing papers authored by Kosta Kostov

Since Specialization
Citations

This map shows the geographic impact of Kosta Kostov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosta Kostov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosta Kostov more than expected).

Fields of papers citing papers by Kosta Kostov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosta Kostov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosta Kostov. The network helps show where Kosta Kostov may publish in the future.

Co-authorship network of co-authors of Kosta Kostov

This figure shows the co-authorship network connecting the top 25 collaborators of Kosta Kostov. A scholar is included among the top collaborators of Kosta Kostov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosta Kostov. Kosta Kostov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Papathanasiou, Jannis, et al.. (2022). Is telerehabilitation a top priority for the Bulgarian healthcare system in the post COVID-19 era?. Health Policy and Technology. 11(4). 100664–100664. 4 indexed citations
2.
Kostov, Kosta, et al.. (2021). REVIEW ON ELECTROENCEPHALOGRAPHIC FINDINGS IN PATIENTS WITH ALZHEIMER'S DISEASE. Journal of IMAB - Annual Proceeding (Scientific Papers). 27(1). 3529–3533. 1 indexed citations
3.
Miravitlles, Marc, Vladimír Koblížek, Cristina Esquinas, et al.. (2019). Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study. Respiratory Medicine. 150. 141–148. 16 indexed citations
4.
Altraja, Alan, А. S. Belevskiy, Piotr Boros, et al.. (2017). Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of COPD. Volume 13. 45–56. 13 indexed citations
5.
Koblížek, Vladimír, Branislava Milenković, Adam Barczyk, et al.. (2017). Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. European Respiratory Journal. 49(5). 1601446–1601446. 76 indexed citations
6.
Tkáčová, Ružena, Jan Švancara, Vladimír Koblížek, et al.. (2016). Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study. PA556–PA556. 1 indexed citations
7.
Kostov, Kosta, et al.. (2009). Acquired nonobstructive urinary bladder diverticulum: a case report. Cases Journal. 2(1). 36–36. 8 indexed citations
8.
Kostov, Kosta, et al.. (2009). Tuberculous spondylitis--analysis of 22 cases.. PubMed. 109(2). 127–31. 5 indexed citations
9.
10.
File, Thomas M., Lionel A. Mandell, Glenn S. Tillotson, Kosta Kostov, & Ognian Georgiev. (2007). Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. Journal of Antimicrobial Chemotherapy. 60(1). 112–120. 54 indexed citations
11.
Markova, Roumiana, et al.. (2007). Genetic Polymorphism of the Chemokine Co-Receptors CCR5, CXCR4 and CCR2 in Bulgarians Living with HIV. Biotechnology & Biotechnological Equipment. 21(3). 328–334. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026